{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:20:00Z","timestamp":1792304400785,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.humpath.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T03:45:50Z","timestamp":1406691950000},"page":"2218-2224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["IMP3 expression is associated with poor survival in cervical squamous cell carcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Qingzhu","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2014.07.006_bb0005","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-10-0437","article-title":"Global patterns of cancer incidence and mortality rates and trends","volume":"19","author":"Jemal","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.humpath.2014.07.006_bb0010","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1470-2045(08)70110-4","article-title":"Heterogeneity in CIN3 diagnosis","volume":"9","author":"Schiffman","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0015","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cncr.25658","article-title":"Prognostic model for survival in patients with early stage cervical cancer","volume":"117","author":"Biewenga","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2014.07.006_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ijc.24716","article-title":"GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer","volume":"126","author":"Li","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2014.07.006_bb0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2012.11.007","article-title":"Loss of ARID1A\/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer","volume":"44","author":"Cho","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.2008.62","article-title":"Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival","volume":"21","author":"Kloth","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0035","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","article-title":"Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?","volume":"70","author":"Bell","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.humpath.2014.07.006_bb0040","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.humpath.2010.06.003","article-title":"The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology","volume":"42","author":"Findeis-Hosey","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0045","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/carcin\/bgs258","article-title":"Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression","volume":"33","author":"Hwang","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2014.07.006_bb0050","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/hed.21929","article-title":"Role of insulin-like growth factor-II mRNA-binding protein-3 in invadopodia formation and the growth of oral squamous cell carcinoma in athymic nude mice","volume":"34","author":"Hwang","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.humpath.2014.07.006_bb0055","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601039","article-title":"RNA-binding IMPs promote cell adhesion and invadopodia formation","volume":"25","author":"Vikesaa","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.humpath.2014.07.006_bb0060","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.humpath.2013.04.011","article-title":"IMP3 as a supplemental diagnostic marker for Hodgkin lymphoma","volume":"44","author":"Tang","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0065","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.humpath.2012.12.020","article-title":"Insulin-like growth factor II messenger RNA\u2013binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm","volume":"44","author":"Morimatsu","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1365-2559.2011.04091.x","article-title":"Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value","volume":"60","author":"Wachter","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2014.07.006_bb0075","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1038\/onc.2011.620","article-title":"Regulation of IMP3 by EGFR signaling and repression by ERbeta: implications for triple-negative breast cancer","volume":"31","author":"Samanta","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2014.07.006_bb0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.juro.2013.08.048","article-title":"Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder","volume":"191","author":"Xylinas","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0085","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1245\/s10434-009-0648-5","article-title":"IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis","volume":"16","author":"Li","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0090","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/PAS.0b013e31823272d4","article-title":"IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer","volume":"35","author":"Lu","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.humpath.2011.12.020","article-title":"Oncofetal protein IMP3: a useful diagnostic biomarker for leiomyosarcoma","volume":"43","author":"Cornejo","year":"2012","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2014.07.006_bb0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1464-410X.2011.10703.x","article-title":"Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy","volume":"110","author":"Chromecki","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2014.07.006_bb0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1464-410X.2012.11149.x","article-title":"High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer","volume":"110","author":"Szarvas","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.humpath.2014.07.006_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.humpath.2014.07.006_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1479-5876-10-141","article-title":"Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens","volume":"10","author":"Kono","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.humpath.2014.07.006_bb0120","first-page":"57","article-title":"Significant clinical response of advanced colon cancer to peptide vaccine therapy: a case report","volume":"37","author":"Yasuda","year":"2012","journal-title":"Tokai J Exp Clin Med"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714002883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817714002883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T08:28:27Z","timestamp":1538382507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817714002883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0046817714002883"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2014.07.006","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IMP3 expression is associated with poor survival in cervical squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}